These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Human liver cytochrome P450 enzymes involved in the 7-hydroxylation of R- and S-warfarin enantiomers. Yamazaki H; Shimada T Biochem Pharmacol; 1997 Dec; 54(11):1195-203. PubMed ID: 9416970 [TBL] [Abstract][Full Text] [Related]
25. Human cytochromes P4501A1 and P4501A2: R-warfarin metabolism as a probe. Zhang Z; Fasco MJ; Huang Z; Guengerich FP; Kaminsky LS Drug Metab Dispos; 1995 Dec; 23(12):1339-46. PubMed ID: 8689941 [TBL] [Abstract][Full Text] [Related]
26. When the INR comes back too high. Gerstein FH; Evans MF Can Fam Physician; 1998 Sep; 44():1841-2. PubMed ID: 9789664 [No Abstract] [Full Text] [Related]
27. [Antivitamin K and paracetamol, an undesirable synergy]. Chiche GJ Presse Med; 2001 May 26-Jun 2; 30(19):976. PubMed ID: 11433734 [No Abstract] [Full Text] [Related]
28. Drug-drug interactions in an era of multiple anticoagulants: a focus on clinically relevant drug interactions. Vazquez SR Blood; 2018 Nov; 132(21):2230-2239. PubMed ID: 30463993 [TBL] [Abstract][Full Text] [Related]
29. Hepatic cytochrome P450 mediates interaction between warfarin and Coleus forskohlii extract in vivo and in vitro. Yokotani K; Chiba T; Sato Y; Taki Y; Yamada S; Shinozuka K; Murata M; Umegaki K J Pharm Pharmacol; 2012 Dec; 64(12):1793-801. PubMed ID: 23146043 [TBL] [Abstract][Full Text] [Related]
30. Does differing metabolism by cytochrome p450 have clinical importance? Davidson MH Curr Atheroscler Rep; 2000 Jan; 2(1):14-9. PubMed ID: 11122720 [TBL] [Abstract][Full Text] [Related]
31. Catalysis of the cysteine conjugation and protein binding of acetaminophen by microsomes from a human lymphoblast line transfected with the cDNAs of various forms of human cytochrome P450. Zhou L; Erickson RR; Hardwick JP; Park SS; Wrighton SA; Holtzman JL J Pharmacol Exp Ther; 1997 May; 281(2):785-90. PubMed ID: 9152386 [TBL] [Abstract][Full Text] [Related]
32. Phytonadione therapy in a multiple-drug overdose involving warfarin. Bates D; Mintz M Pharmacotherapy; 2000 Oct; 20(10):1208-15. PubMed ID: 11034045 [TBL] [Abstract][Full Text] [Related]
33. Warfarin analog inhibition of human CYP2C9-catalyzed S-warfarin 7-hydroxylation. Zhang ZY; Kerr J; Wexler RS; Li HY; Robinson AJ; Harlow PP; Kaminsky LS Thromb Res; 1997 Nov; 88(4):389-98. PubMed ID: 9526963 [TBL] [Abstract][Full Text] [Related]
34. Structural forms of phenprocoumon and warfarin that are metabolized at the active site of CYP2C9. He M; Korzekwa KR; Jones JP; Rettie AE; Trager WF Arch Biochem Biophys; 1999 Dec; 372(1):16-28. PubMed ID: 10562412 [TBL] [Abstract][Full Text] [Related]
35. Genetic regulation of warfarin metabolism and response. Daly AK; Aithal GP Semin Vasc Med; 2003 Aug; 3(3):231-8. PubMed ID: 15199455 [TBL] [Abstract][Full Text] [Related]
36. Potentiation of the acenocoumarol anticoagulant effect by acetaminophen. Bagheri H; Bernhard NB; Montastruc JL Ann Pharmacother; 1999 Apr; 33(4):506. PubMed ID: 10332548 [No Abstract] [Full Text] [Related]
37. Moxifloxacin-acetaminophen-warfarin interaction during bacille Calmette-Guerin treatment for bladder cancer. Lee R; Wen A; Berube C Am J Health Syst Pharm; 2011 May; 68(9):814-7. PubMed ID: 21515865 [TBL] [Abstract][Full Text] [Related]
38. Disposition of drugs in cystic fibrosis. VI. In vivo activity of cytochrome P450 isoforms involved in the metabolism of (R)-warfarin (including P450 3A4) is not enhanced in cystic fibrosis. Wang JP; Unadkat JD; McNamara S; O'Sullivan TA; Smith AL; Trager WF; Ramsey B Clin Pharmacol Ther; 1994 May; 55(5):528-34. PubMed ID: 8181197 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of a potential enantioselective interaction between ticlopidine and warfarin in chronically anticoagulated patients. Gidal BE; Sorkness CA; McGill KA; Larson R; Levine RR Ther Drug Monit; 1995 Feb; 17(1):33-8. PubMed ID: 7725374 [TBL] [Abstract][Full Text] [Related]